Adam Pawinski
Overview
Explore the profile of Adam Pawinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nieder C, Dalhaug A, Haukland E, Mannsaker B, Pawinski A
Int J Circumpolar Health
. 2017 Apr;
76(1):1270080.
PMID: 28452680
The aim of this study was to reduce barriers that prevent implementation of evidence-based recommendations about single-fraction palliative radiotherapy (PRT) and to demonstrate that single-fraction PRT yields similar outcomes as...
12.
Nieder C, Dalhaug A, Haukland E, Mannsaker B, Pawinski A
J Clin Med Res
. 2017 Feb;
9(3):183-187.
PMID: 28179964
Background: The aim of the study was to explore the prognostic impact of different abnormal blood tests and the tumor marker CA 15-3 as well as established parameters such as...
13.
Nieder C, Mannsaker B, Pawinski A, Haukland E
Anticancer Res
. 2017 Feb;
37(2):795-799.
PMID: 28179332
Background/aim: Many older cancer patients receive five or more daily medications (polypharmacy). The purpose of this study was to assess the prevalence of polypharmacy in older patients undergoing palliative radiotherapy...
14.
Nieder C, Dalhaug A, Pawinski A, Mannsaker B, Haukland E
In Vivo
. 2016 Nov;
30(6):879-883.
PMID: 27815475
Background/aim: Patients with bone-only metastases survive longer than patients with widespread visceral disease. We analyzed the prognostic impact of different baseline parameters, such as abnormal blood tests and receptor status...
15.
Nieder C, Mannsaker B, Dalhaug A, Pawinski A, Haukland E
In Vivo
. 2016 Aug;
30(5):581-6.
PMID: 27566075
Background/aim: Connections exist between inflammation and cancer, for example with regard to disease progression and prognosis. Therefore, we investigated whether systemic inflammatory processes indicated by increased serum C-reactive protein (CRP)...
16.
Nieder C, Angelo K, Dalhaug A, Pawinski A, Haukland E, Norum J
Oncol Lett
. 2016 Jan;
10(5):3043-3049.
PMID: 26722287
Oncologists commonly overestimate the survival time of patients receiving palliative therapy, which may result in the administration of treatments that are too aggressive for patients near the end of their...
17.
Nieder C, Dalhaug A, Pawinski A, Haukland E, Mannsaker B, Engljahringer K
Radiat Oncol
. 2015 Apr;
10:61.
PMID: 25889414
Purpose: To analyze survival after early palliative radiotherapy (RT) in patients managed exclusively by regular oncology staff or a multidisciplinary palliative care team (MPCT) in addition. Methods: Retrospective matched pairs...
18.
Nieder C, Haukland E, Mannsaker B, Pawinski A, Dalhaug A
Pract Radiat Oncol
. 2015 Apr;
5(5):e537-e542.
PMID: 25823382
Purpose: To analyze indications for early palliative radiation therapy (RT) (ie, start within 1 month from cancer diagnosis), regimens used in clinical practice, rate of treatment completion and treatment in...
19.
Nieder C, Dalhaug A, Haukland E, Mannsaker B, Pawinski A
Tumour Biol
. 2015 Mar;
36(8):6471-6.
PMID: 25801247
This study aims to explore patterns of practice of tumor marker analyses and potential prognostic impact of abnormal markers in patients with brain metastases from solid tumors. Previously, lactate dehydrogenase...
20.
Nieder C, Angelo K, Haukland E, Pawinski A
Anticancer Res
. 2014 Nov;
34(11):6641-5.
PMID: 25368269
Background/aim: Older cancer patients might experience inferior survival outcomes. However, no standard age cut-off is currently being used for commonly administered treatments such as radiotherapy. We evaluated survival outcomes and...